Pfizer says COVID vaccine safe and 'robust' for children aged 5 to 11 The pharmaceutical company is now planning to send its research to regulators soon.
, showed a"favorable safety profile and robust neutralizing antibody responses" in the age group.
"Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine," said Pfizer CEO Albert Bourla. "We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children.
"Since July, pediatric cases of COVID-19 have risen by about 240 percent in the U.S.—underscoring the public health need for vaccination. These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to theA nurse shows a container of Pfizer-BioNTech COVID-19 vaccine after it was used to vaccinate the first five staff members at Roseland Community Hospital on December 17, 2020 in Chicago, Illinois.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11The drugmaker said it will seek emergency use authorization for this age group in the U.S. by the end of the month.
Consulte Mais informação »
Pfizer says COVID-19 vaccine safe, effective for kids ages 5 to 11Pfizer and BioNTech released data saying its vaccine is safe and effective for kids 5-11.
Consulte Mais informação »
Pfizer says COVID-19 vaccine works in kids ages 5 to 11Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.
Consulte Mais informação »
Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11Pfizer Inc. undefined and German partner BioNTech SE undefined on Monday announced positive results in a Phase 2/3 trial of their COVID-19 vaccine in...
Consulte Mais informação »
Pfizer says COVID-19 vaccine works in kids ages 5 to 11, will seek authorizationPfizer said its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
Consulte Mais informação »